Stock XGN EXAGEN INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Exagen Inc.

Equities

XGN

US30068X1037

Market Closed - Nasdaq
Other stock markets
 16:30:01 2024-04-26 EDT 		5-day change 1st Jan Change
1.412 USD +0.15% Intraday chart for Exagen Inc. +3.07% -29.04%
04-26 Exagen Inc. Announces Changes in Board of Directors CI
03-18 Exagen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on Exagen Inc.

Price target over the last 5 years

History of analyst recommendation changes

82e663c634146124f64205f2ad810a54.32-SQpPsI8GW_M_dvumsrkKG_-arRU4lejMIiI5hG6U.igP2JMCJF5XFrf3s-4ecynDepbnSPx4ISnZPy-hMes-9KPw08J5XqcOM-w~2aca3b012c1b78f65b849631de50eb42

Analyst Recommendations on Exagen Inc.

BTIG Adjusts Price Target on Exagen to $5 From $6, Maintains Buy Rating MT
BTIG Adjusts Exagen's Price Target to $7 From $10, Keeps Buy Rating MT
Canaccord Genuity Cuts Price Target on Exagen to $7 From $8, Affirms Buy Rating MT
KeyBanc Downgrades Exagen to Sector Weight From Overweight, Citing 'Uncertain Test Pricing Process' MT
KeyBanc Lowers Exagen's Price Target to $17 From $20, Maintains Overweight Rating MT
KeyBanc Adjusts Exagen's Price Target to $20 From $30, Reiterates Overweight Rating MT
Cowen Adjusts Exagen's Price Target to $16 from $26, Reiterates Outperform Rating MT
KeyBanc Adjusts Price Target on Exagen to $30 from $33, Keeps Overweight Rating MT
EXAGEN : BTIG Adjusts Exagen's Price Target to $20 From $23, Reiterates Buy Rating MT
EXAGEN : Canaccord Genuity Initiates Exagen at Buy Rating With $25 Price Target MT
EXAGEN : KeyBanc Initiates Exagen at Overweight with $32 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1.412 USD
Average target price
5.5 USD
Spread / Average Target
+289.49%
High Price Target
7 USD
Spread / Highest target
+395.72%
Low Price Target
5 USD
Spread / Lowest Target
+254.08%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Exagen Inc.

BTIG
Canaccord Genuity
KeyBanc Capital Markets
Cowen

Ratings for Exagen Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. XGN Stock
  4. Consensus Exagen Inc.